| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/13/2001 | WO2001042479A3 Insecticide targets and methods of use |
| 12/13/2001 | WO2001040475A3 Heme proteins hemat-hs and hemat-bs and their use in medicine and microsensors |
| 12/13/2001 | WO2001038502A3 Oleoyl-acyl-carrier-protein thioesterases in plants |
| 12/13/2001 | WO2001037881A3 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 12/13/2001 | WO2001036681A3 Immunological detection of rna:dna hybrids on microarrays |
| 12/13/2001 | WO2001032852A3 Method for directed packaging of molecular substances in protein shells |
| 12/13/2001 | WO2001032829A3 Methods to screen microorganisms or gene libraries for products secreted from a cell |
| 12/13/2001 | WO2001030987A3 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 12/13/2001 | WO2001030977A3 5r clavam producing microorganisms with deleted lat and cvm genes |
| 12/13/2001 | WO2001025487A3 Electrochemiluminescence helicase assay |
| 12/13/2001 | WO2001021785A3 Megagametophyte transcriptional control elements and uses thereof |
| 12/13/2001 | WO2001021650A3 Cis-prenyltransferases from plants |
| 12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 12/13/2001 | WO2001011088A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 12/13/2001 | WO2001011048A3 Therapeutic polypeptides and methods for using same |
| 12/13/2001 | WO2001011038A3 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 12/13/2001 | WO2001010220A3 Insect control system |
| 12/13/2001 | WO2001004150A3 Neisseria meningitidis compounds and anti-infection applications thereof |
| 12/13/2001 | WO2000065076A3 Synthetic gene for expressing active retroviral protein in eukaryotes |
| 12/13/2001 | WO2000058514A3 Methods for improving sensitivity and specificity of screening assays |
| 12/13/2001 | WO2000044888A3 Dimethylarginine dimethylaminohydrolases |
| 12/13/2001 | WO2000032773A9 Compositions and methods for increasing bone mineralization |
| 12/13/2001 | WO2000029008A9 Hiv-specific t-cell induction |
| 12/13/2001 | WO2000026340A3 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 12/13/2001 | WO2000023564A3 Protein design automation for protein libraries |
| 12/13/2001 | WO2000018903A9 Inducible genetic suppression of cellular excitability |
| 12/13/2001 | WO2000015849A9 Artificial long terminal repeat vectors |
| 12/13/2001 | WO2000015845A9 T-type calcium channel |
| 12/13/2001 | WO2000014115A9 Mc4-r as target for the identification of compounds used to treat drug addiction |
| 12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
| 12/13/2001 | WO1999061634A9 Method of producing thy a-strains of vibrio cholerae, such strains and their use |
| 12/13/2001 | WO1999043783A3 TRANSGENIC MOUSE HAVING A LacZ REPORTER GENE UNDER THE CONTROL OF THE N-CAM PROMOTER |
| 12/13/2001 | US20010052140 Preferential recovery of genetically engineered corn plant; propagate mated plants, determine expression pattern of preferential genes, recover plants with preferential phenotype |
| 12/13/2001 | US20010052139 Novel genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use |
| 12/13/2001 | US20010051713 DNA comprising rice anther-specific gene and transgenic plant transformed therewith |
| 12/13/2001 | US20010051611 Supplying protein, antibodies, ribozymes |
| 12/13/2001 | US20010051610 Using transition metal compound promoter |
| 12/13/2001 | US20010051375 Highly efficient gene transfer into human repopulating stem cells by RD114 pseudotyped retroviral vector particles |
| 12/13/2001 | US20010051374 High efficiency genetic modification methods |
| 12/13/2001 | US20010051372 Monoclonal immunoglublin; for use in gene therapy and cell transplantation |
| 12/13/2001 | US20010051370 Glycosyl sulfotransferase-3 |
| 12/13/2001 | US20010051369 Variant galactose oxidase, nucleic acid encoding same, and methods of using same |
| 12/13/2001 | US20010051366 Transferring particles through cell barriers; insert cell into electrically conductive fluid, monitor electrical current, adjust voltage to maintain preferential diffusion |
| 12/13/2001 | US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | US20010051360 Preferential peptide; for use in the treatment of kinase defects; for treatment of cancer |
| 12/13/2001 | US20010051359 Genetic engineered protein |
| 12/13/2001 | US20010051356 Genetic engineering |
| 12/13/2001 | US20010051336 Nucleotide-protein fusion; for use as a diagnostic tool in the decision of preferential particles |
| 12/13/2001 | US20010051113 Determinating nucleotide polymorphism |
| 12/13/2001 | DE10113781A1 New DNA encoding synthetic spider silk protein, useful e.g. for closing wounds, comprises modules that encode repeating units of spirodoin proteins |
| 12/13/2001 | DE10027777A1 Introducing substances into cells of sensory organs, useful for treating degenerative disorders of ear and eye, uses penetratin as transporter molecule |
| 12/13/2001 | DE10027397A1 Oberfläche zur Immobilisierung von Liganden Surface for immobilization of ligands |
| 12/13/2001 | DE10027170A1 Humanes PEM als Target für die Fertilitätskontrolle Human PEM as a target for fertility control |
| 12/13/2001 | DE10026833A1 Verfahren zur Identifizierung von Verbindungen zur Modulierung der Aktivität eines Tumorsuppressorgens A method for identifying compounds for modulating the activity of a tumor suppressor |
| 12/13/2001 | DE10025609A1 Transfektionssystem Transfection |
| 12/13/2001 | CA2810249A1 Identification and use of human bone marrow-derived endothelial progenitor cell to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2707766A1 Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 12/13/2001 | CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591656A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2591583A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/13/2001 | CA2585822A1 Breast, rectal, colon and lung tumour marker pro19628 polypeptide and encoding nucleic acid |
| 12/13/2001 | CA2416868A1 Identification and use of molecular markers indicating cellular reprogramming |
| 12/13/2001 | CA2412567A1 Charge-switch nucleotides |
| 12/13/2001 | CA2412436A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 12/13/2001 | CA2412413A1 Asynchronous primed pcr |
| 12/13/2001 | CA2412382A1 Hy2 family of bilin reductases |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2412374A1 Novel leader peptides for enhancing secretion of recombinant protein from a host cell |
| 12/13/2001 | CA2412026A1 Immunostimulatory rna/dna hybrid molecules |
| 12/13/2001 | CA2411730A1 Tumour suppressor and uses thereof |
| 12/13/2001 | CA2411719A1 Novel g-protein coupled receptor |
| 12/13/2001 | CA2411609A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 12/13/2001 | CA2411601A1 Cancer gene determination and therapeutic screening using signature gene sets |
| 12/13/2001 | CA2411600A1 Synthetic spider silk proteins and the expression thereof in transgenic plants |
| 12/13/2001 | CA2411575A1 Immunostimulatory oligodeoxynucleotides |
| 12/13/2001 | CA2411573A1 Method and apparatus for washing and drying pins in microarray spotting instruments |
| 12/13/2001 | CA2411542A1 Encapsulation of polynucleotides and drugs into targeted liposomes |
| 12/13/2001 | CA2411541A1 High level production of p-hydroxybenzoic acid in green plants |
| 12/13/2001 | CA2411473A1 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 12/13/2001 | CA2411470A1 T cell receptor fusions and conjugates and methods of use thereof |
| 12/13/2001 | CA2411439A1 Tyrosine kinase modulators |
| 12/13/2001 | CA2411285A1 Combined preparation for the treatment of neoplasic diseases |
| 12/13/2001 | CA2411247A1 Fatty acid elongase 3-ketoacyl coa synthase polypeptides |
| 12/13/2001 | CA2411139A1 Inhibitors of c-reactive protein induced inflammation |
| 12/13/2001 | CA2411101A1 A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof |
| 12/13/2001 | CA2411072A1 Method to detect modulators of vegf kinase domain |
| 12/13/2001 | CA2411069A1 The human voltage gated sodium channel .beta.-1a subunit and methods of use |
| 12/13/2001 | CA2410879A1 Novel compositions and methods for array-based nucleic acid hybridization |
| 12/13/2001 | CA2410492A1 Method of using dna episomes to suppress gene expression in plants |
| 12/13/2001 | CA2410490A1 Method of using dna episomes to suppress gene expression in plants |
| 12/13/2001 | CA2410458A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury |
| 12/13/2001 | CA2410440A1 Methods for improving the sequence fidelity of synthetic double-stranded oligonucleotides |
| 12/13/2001 | CA2410281A1 Methods and devices for multiplexing amplification reactions |
| 12/13/2001 | CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | CA2410184A1 Processing of plasmid-containing fluids |
| 12/13/2001 | CA2410162A1 Breast, rectal, colon and lung tumor marker pro 4332 polypeptide and encoding nucleic acid |